dr. shuren, the industry and the fda agreed to have an independent, two-phase assessment and program evaluation to object ily assess the fda's premarket review process. can you explain how fda was involved in setting the parameters of this assessment? >> certainly. we put out calls for independent contractors -- [inaudible] and that was a -- my acoldies. we had put out a call to have an independent contractor perform the assessment, and booz allen hamilton is that contractor. we worked on a draft statement of work which we put out to the public for comment. we had discussions with industry on what should go into that statement of work, and then finally, we've been overseeing the process for the contractor. we get updates on the progress they make, but it is independent, so we don't know what they're actually going to report to us. our understanding is they have gone out, they have had conversations with stakeholders, particularly industry, they've conducted focus groups, and we're expecting to get their first report very soon, and we have a public commitment to make that available to the public